ICON PLC
NASDAQ: ICLR · HEALTHCARE · DIAGNOSTICS & RESEARCH
Updated 2026-06-05
ICON PLC (ICLR) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $455.60M | $38.30M | 43.75% | 10.50% | 8.41% |
| 2007 | $630.72M | $55.96M | 43.80% | 10.98% | 8.87% |
| 2008 | $865.25M | $78.12M | 43.46% | 11.50% | 9.03% |
| 2009 | $887.61M | $94.30M | 42.79% | 12.11% | 10.62% |
| 2010 | $900.04M | $87.07M | 39.85% | 10.23% | 9.67% |
| 2011 | $945.73M | $22.88M | 35.30% | 4.15% | 2.42% |
| 2012 | $1.12B | $55.42M | 35.59% | 6.50% | 4.97% |
| 2013 | $1.34B | $102.81M | 36.72% | 9.07% | 7.70% |
| 2014 | $1.50B | $172.47M | 39.92% | 13.46% | 11.47% |
| 2015 | $1.57B | $239.54M | 42.29% | 17.88% | 15.21% |
| 2016 | $1.67B | $262.18M | 42.31% | 18.70% | 15.73% |
| 2017 | $1.76B | $281.49M | 41.34% | 19.24% | 16.01% |
| 2018 | $2.60B | $322.82M | 29.64% | 14.38% | 12.44% |
| 2019 | $2.81B | $373.99M | 29.64% | 15.45% | 13.33% |
| 2020 | $2.80B | $327.81M | 28.89% | 14.00% | 11.72% |
| 2021 | $5.48B | $153.19M | 27.52% | 6.91% | 2.79% |
| 2022 | $7.74B | $505.30M | 28.60% | 10.27% | 6.53% |
| 2023 | $8.12B | $612.34M | 29.56% | 11.78% | 7.54% |
| 2024 | $8.28B | $791.47M | 29.42% | 13.26% | 9.56% |
| 2025 | $8.25B | $229.34M | 26.37% | 12.27% | 2.78% |
Frequently asked questions
What is ICON PLC's revenue?
ICON PLC's trailing twelve-month revenue is $8.25B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is ICLR?
In its most recent fiscal year, ICLR ran a gross margin of 26.37%, an operating margin of 12.27%, and a net margin of 2.78%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does ICLR generate?
ICLR produced $861.99M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is ICLR's balance sheet healthy?
ICLR holds $647.29M in cash and equivalents against $2.87B in long-term debt, on $9.19B of shareholder equity. That debt is best read against the cash flow the business throws off each year.